Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Nov;81(5):814–821. doi: 10.1038/sj.bjc.6690769

New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis

J Tian 1, Z Y Tang 1, S L Ye 1, Y K Liu 1, Z Y Lin 1, J Chen 1, Q Xue 1
PMCID: PMC2374300  PMID: 10555751

Abstract

A new human hepatocellular carcinoma (HCC) cell line with a highly metastatic potential was established from subcutaneous xenograft of a metastatic model of human HCC in nude mice (LCI-D20) by means of alternating cell culture in vitro and growth in nude mice. The line, designated MHCC97, has been cultivated for 18 months and subcultured for more than 90 passages. The line was showed to be of human origin by karyotype analysis. The cells were either grown as compact colonies (in clusters) or as a monolayered sheet with about 31 h of population-doubling time, exhibited typical malignant epithelial in morphology and were positive for α-fetoprotein (AFP). Flow cytometric analysis of the cell DNA content showed an aneuploid pattern, and its index was 1.5 as compared to that of normal human peripheral blood lymphocytes. Karyotypic analyses of G- and C-banding techniques revealed that all cells presented chromosome abnormalities in number and structure. The number of cell line MHCC97 chromosome ranged from 59 to 65 with a modal number of 60 and 61. At least two common chromosome markers, i(1q) and der(4)t(4;?)(4pter→q35::?), were present in all cells, and deletion of Y chromosome also occurred in all cells. The subcutaneous and intrahepatic xenografts were formed and metastatic lesions in lungs were found after the cells were inoculated into nude mice. The rate of metastasis to lungs was 100% using orthotopic inoculation. Reverse transcription polymerase chain reaction products revealed positive expressions of integrin α5 and β1, urokinase type plasminogen activator receptor (uPAR), vascular endothelial growth factor and nm23-H1 mRNAs of cell line MHCC97. Immunostaining of c-Met, uPAR showed strongly positive in both subcutaneous xenografts and lung metastatic lesions; while positive in xenografts and negative in metastatic lesions for integrin α5, β1. E-cadherin and P53 was not expressed either in xenograft or in the metastatic lesions. PCR products of HBsAg and HBxAg were both positive. The cell line MHCC97 still retained some characteristic features of original tumour. Establishment of cell line MHCC97 should be beneficial to the studies of HCC metastatic mechanisms. © 1999 Cancer Research Campaign

Keywords: hepatocellular carcinoma, establishment, cell culture, cell line, metastasis, metastasis-associated factors

Full Text

The Full Text of this article is available as a PDF (405.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albelda S. M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest. 1993 Jan;68(1):4–17. [PubMed] [Google Scholar]
  2. Alexander J. J., Bey E. M., Geddes E. W., Lecatsas G. Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J. 1976 Dec 18;50(54):2124–2128. [PubMed] [Google Scholar]
  3. Amadori D., Bertoni L., Flamigni A., Savini S., De Giovanni C., Casanova S., De Paola F., Amadori A., Giulotto E., Zoli W. Establishment and characterization of a new cell line from primary human breast carcinoma. Breast Cancer Res Treat. 1993 Dec;28(3):251–260. doi: 10.1007/BF00666586. [DOI] [PubMed] [Google Scholar]
  4. Anderson B. B., Ukah F., Tette A., Villaflor S. G., Koh D., Seton P. Primary tumors of the liver. J Natl Med Assoc. 1992 Feb;84(2):129–135. [PMC free article] [PubMed] [Google Scholar]
  5. Aznavoorian S., Murphy A. N., Stetler-Stevenson W. G., Liotta L. A. Molecular aspects of tumor cell invasion and metastasis. Cancer. 1993 Feb 15;71(4):1368–1383. doi: 10.1002/1097-0142(19930215)71:4<1368::aid-cncr2820710432>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  6. Bardi G., Johansson B., Pandis N., Heim S., Mandahl N., Andrén-Sandberg A., Hägerstrand I., Mitelman F. Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet. 1992 Feb;58(2):191–195. doi: 10.1016/0165-4608(92)90111-k. [DOI] [PubMed] [Google Scholar]
  7. Bishop J. M. Molecular themes in oncogenesis. Cell. 1991 Jan 25;64(2):235–248. doi: 10.1016/0092-8674(91)90636-d. [DOI] [PubMed] [Google Scholar]
  8. Blasi F. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. Bioessays. 1993 Feb;15(2):105–111. doi: 10.1002/bies.950150206. [DOI] [PubMed] [Google Scholar]
  9. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. doi: 10.1083/jcb.119.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. CH'EN J. M. The establishment of a strain of human liver cell carcinoma in vitro and some preliminary observations. Chin Med J. 1963 Apr;82:228–237. [PubMed] [Google Scholar]
  11. Chen H. L., Chiu T. S., Chen P. J., Chen D. S. Cytogenetic studies on human liver cancer cell lines. Cancer Genet Cytogenet. 1993 Feb;65(2):161–166. doi: 10.1016/0165-4608(93)90227-d. [DOI] [PubMed] [Google Scholar]
  12. Ellis V., Pyke C., Eriksen J., Solberg H., Danø K. The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann N Y Acad Sci. 1992 Dec 4;667:13–31. doi: 10.1111/j.1749-6632.1992.tb51591.x. [DOI] [PubMed] [Google Scholar]
  13. Fidler I. J., Ellis L. M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 1994 Oct 21;79(2):185–188. doi: 10.1016/0092-8674(94)90187-2. [DOI] [PubMed] [Google Scholar]
  14. Frixen U. H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Löchner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991 Apr;113(1):173–185. doi: 10.1083/jcb.113.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fujimori M., Tokino T., Hino O., Kitagawa T., Imamura T., Okamoto E., Mitsunobu M., Ishikawa T., Nakagama H., Harada H. Allelotype study of primary hepatocellular carcinoma. Cancer Res. 1991 Jan 1;51(1):89–93. [PubMed] [Google Scholar]
  16. Giancotti F. G., Ruoslahti E. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell. 1990 Mar 9;60(5):849–859. doi: 10.1016/0092-8674(90)90098-y. [DOI] [PubMed] [Google Scholar]
  17. Giard D. J., Aaronson S. A., Todaro G. J., Arnstein P., Kersey J. H., Dosik H., Parks W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. doi: 10.1093/jnci/51.5.1417. [DOI] [PubMed] [Google Scholar]
  18. Grant D. S., Kleinman H. K., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P., Rosen E. M. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. doi: 10.1073/pnas.90.5.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hambly R. J., Double J. A., Thompson M. J., Bibby M. C. Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude mice. Breast Cancer Res Treat. 1997 May;43(3):247–258. doi: 10.1023/a:1005756632293. [DOI] [PubMed] [Google Scholar]
  20. He L., Isselbacher K. J., Wands J. R., Goodman H. M., Shih C., Quaroni A. Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro. 1984 Jun;20(6):493–504. doi: 10.1007/BF02619623. [DOI] [PubMed] [Google Scholar]
  21. Hsu T., Möröy T., Etiemble J., Louise A., Trépo C., Tiollais P., Buendia M. A. Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma. Cell. 1988 Nov 18;55(4):627–635. doi: 10.1016/0092-8674(88)90221-8. [DOI] [PubMed] [Google Scholar]
  22. Igawa M., Rukstalis D. B., Tanabe T., Chodak G. W. High levels of nm23 expression are related to cell proliferation in human prostate cancer. Cancer Res. 1994 Mar 1;54(5):1313–1318. [PubMed] [Google Scholar]
  23. Jeffers M., Rong S., Vande Woude G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol. 1996 Mar;16(3):1115–1125. doi: 10.1128/mcb.16.3.1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Koch A. E., Harlow L. A., Haines G. K., Amento E. P., Unemori E. N., Wong W. L., Pope R. M., Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994 Apr 15;152(8):4149–4156. [PubMed] [Google Scholar]
  25. Kuroki T., Fujiwara Y., Nakamori S., Imaoka S., Kanematsu T., Nakamura Y. Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer. 1995 Aug;72(2):383–385. doi: 10.1038/bjc.1995.342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Liao S. K., Dent P. B., McCulloch P. B. Characterization of human maligant melanoma cell lines. I. Morphology and growth characteristics in culture. J Natl Cancer Inst. 1975 May;54(5):1037–1044. [PubMed] [Google Scholar]
  27. Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem. 1996 Apr;119(4):591–600. doi: 10.1093/oxfordjournals.jbchem.a021283. [DOI] [PubMed] [Google Scholar]
  28. Meltzer P., Leibovitz A., Dalton W., Villar H., Kute T., Davis J., Nagle R., Trent J. Establishment of two new cell lines derived from human breast carcinomas with HER-2/neu amplification. Br J Cancer. 1991 May;63(5):727–735. doi: 10.1038/bjc.1991.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Miyasaka M. Cancer metastasis and adhesion molecules. Clin Orthop Relat Res. 1995 Mar;(312):10–18. [PubMed] [Google Scholar]
  30. Murakami Y., Hayashi K., Hirohashi S., Sekiya T. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res. 1991 Oct 15;51(20):5520–5525. [PubMed] [Google Scholar]
  31. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 1992 Dec;11(13):4825–4833. doi: 10.1002/j.1460-2075.1992.tb05588.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nigam A. K., Pignatelli M., Boulos P. B. Current concepts in metastasis. Gut. 1994 Jul;35(7):996–1000. doi: 10.1136/gut.35.7.996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nishida N., Fukuda Y., Kokuryu H., Sadamoto T., Isowa G., Honda K., Yamaoka Y., Ikenaga M., Imura H., Ishizaki K. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer. 1992 Jul 30;51(6):862–868. doi: 10.1002/ijc.2910510605. [DOI] [PubMed] [Google Scholar]
  34. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992 May;15(5):948–963. doi: 10.1002/hep.1840150532. [DOI] [PubMed] [Google Scholar]
  35. Park J. G., Frucht H., LaRocca R. V., Bliss D. P., Jr, Kurita Y., Chen T. R., Henslee J. G., Trepel J. B., Jensen R. T., Johnson B. E. Characteristics of cell lines established from human gastric carcinoma. Cancer Res. 1990 May 1;50(9):2773–2780. [PubMed] [Google Scholar]
  36. Parkin D. M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer. 1993 Jun 19;54(4):594–606. doi: 10.1002/ijc.2910540413. [DOI] [PubMed] [Google Scholar]
  37. Pasquinelli C., Garreau F., Bougueleret L., Cariani E., Grzeschik K. H., Thiers V., Croissant O., Hadchouel M., Tiollais P., Bréchot C. Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J Virol. 1988 Feb;62(2):629–632. doi: 10.1128/jvi.62.2.629-632.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Rheinwald J. G., Beckett M. A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res. 1981 May;41(5):1657–1663. [PubMed] [Google Scholar]
  39. Rogler C. E., Sherman M., Su C. Y., Shafritz D. A., Summers J., Shows T. B., Henderson A., Kew M. Deletion in chromosome 11p associated with a hepatitis B integration site in hepatocellular carcinoma. Science. 1985 Oct 18;230(4723):319–322. doi: 10.1126/science.2996131. [DOI] [PubMed] [Google Scholar]
  40. Schreiner C., Fisher M., Hussein S., Juliano R. L. Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res. 1991 Mar 15;51(6):1738–1740. [PubMed] [Google Scholar]
  41. Seabright M. A rapid banding technique for human chromosomes. Lancet. 1971 Oct 30;2(7731):971–972. doi: 10.1016/s0140-6736(71)90287-x. [DOI] [PubMed] [Google Scholar]
  42. Shimoyama Y., Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett. 1991 May 1;57(2):131–135. doi: 10.1016/0304-3835(91)90206-w. [DOI] [PubMed] [Google Scholar]
  43. Simon D., Knowles B. B., Weith A. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas. Oncogene. 1991 May;6(5):765–770. [PubMed] [Google Scholar]
  44. Simon D., Munoz S. J., Maddrey W. C., Knowles B. B. Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet. 1990 Apr;45(2):255–260. doi: 10.1016/0165-4608(90)90091-n. [DOI] [PubMed] [Google Scholar]
  45. Sugimura T. Multistep carcinogenesis: a 1992 perspective. Science. 1992 Oct 23;258(5082):603–607. doi: 10.1126/science.1411570. [DOI] [PubMed] [Google Scholar]
  46. Sun F. X., Tang Z. Y., Lui K. D., Ye S. L., Xue Q., Gao D. M., Ma Z. C. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer. 1996 Apr 10;66(2):239–243. doi: 10.1002/(SICI)1097-0215(19960410)66:2<239::AID-IJC17>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  47. Tom B. H., Rutzky L. P., Oyasu R., Tomita J. T., Goldenberg D. M., Kahan B. D. Human colon adenocarcinoma cells. II. Tumorigenic and organoid expression in vivo and in vitro. J Natl Cancer Inst. 1977 May;58(5):1507–1512. doi: 10.1093/jnci/58.5.1507. [DOI] [PubMed] [Google Scholar]
  48. Weidner K. M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990 Nov;111(5 Pt 1):2097–2108. doi: 10.1083/jcb.111.5.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Weinberg R. A. The integration of molecular genetics into cancer management. Cancer. 1992 Sep 15;70(6 Suppl):1653–1658. doi: 10.1002/1097-0142(19920915)70:4+<1653::aid-cncr2820701603>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  50. Werner M., Nolte M., Georgii A., Klempnauer J. Chromosome 1 abnormalities in hepatocellular carcinoma. Cancer Genet Cytogenet. 1993 Apr;66(2):130–130. doi: 10.1016/0165-4608(93)90243-f. [DOI] [PubMed] [Google Scholar]
  51. Yeh S. H., Chen P. J., Chen H. L., Lai M. Y., Wang C. C., Chen D. S. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 1994 Aug 1;54(15):4188–4192. [PubMed] [Google Scholar]
  52. Yeh S. H., Chen P. J., Lai M. Y., Chen D. S. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: association with elevated alpha-fetoprotein production. Gastroenterology. 1996 Jan;110(1):184–192. doi: 10.1053/gast.1996.v110.pm8536855. [DOI] [PubMed] [Google Scholar]
  53. Zhang W. D., Hirohashi S., Tsuda H., Shimosato Y., Yokota J., Terada M., Sugimura T. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res. 1990 Feb;81(2):108–111. doi: 10.1111/j.1349-7006.1990.tb02534.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES